| Income Statement |
| Operating Expenses | 4.40M |
|
| Research and Development Expense | 649.00K |
| Selling, General and Administrative Expense | 3.56M |
| Operating Income | -4.40M |
| Net Income | -4.32M |
| Net Income Common Stock | -4.32M |
| Net Income Common Stock (USD) | -4.32M |
| Consolidated Income | -4.32M |
| Earnings per Basic Share | -0.03 |
| Earnings per Basic Share (USD) | -0.03 |
| Earnings per Diluted Share | -0.03 |
| Earning Before Interest & Taxes (EBIT) | -4.32M |
| Earning Before Interest & Taxes (USD) | -4.32M |
| Weighted Average Shares | 126.88M |
| Weighted Average Shares Diluted | 126.88M |
| Balance Sheet |
| Cash and Equivalents | 38.20M |
| Cash and Equivalents (USD) | 38.20M |
| Current Assets | 38.84M |
| Property, Plant & Equipment Net | 144.55M |
| Total Assets | 185.97M |
| Debt Current | 2.24M |
| Total Debt | 2.24M |
| Current Liabilities | 7.56M |
| Total Liabilities | 8.94M |
| Accumulated Retained Earnings (Deficit) | -410.00M |
| Shareholders Equity | 177.03M |
| Shareholders Equity (USD) | 177.03M |
| Assets Non-Current | 147.13M |
| Total Debt (USD) | 2.24M |
| Liabilities Non-Current | 1.38M |
| Trade and Non-Trade Payables | 4.28M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 281.00K |
| Net Cash Flow from Financing | -24.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.26M |
| Capital Expenditure | -729.00K |
| Issuance (Purchase) of Equity Shares | -22.00K |
| Issuance (Repayment) of Debt Securities | -2.00K |
| Net Cash Flow from Investing | -729.00K |
| Net Cash Flow from Operations | -2.51M |
| Share Based Compensation | 970.00K |